Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People With Diabetes Who Were Recently Hospitalized
Conclusion: SGLT-2Is may be preferred to DPP-4Is for preventing MACE, HF hospitalizations and mortality in frail people with type 2 diabetes.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Australia Health | Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Haemorrhagic Fever With Renal Syndrome (HFRS) | Heart | Heart Failure | Sodium | Study